Helix BioMedix, Inc. (HXBM)
OTCMKTS · Delayed Price · Currency is USD
1.000
-0.700 (-41.18%)
At close: Mar 11, 2026
Helix BioMedix Market Cap
Helix BioMedix has a market cap or net worth of $224.71 thousand as of March 26, 2026. Its market cap has decreased by -98.26% in one year.
Market Cap
224.71K
Enterprise Value
n/a
Revenue
2.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.00
Market Cap Chart
Since July 26, 1995, Helix BioMedix's market cap has decreased from 1.59M to 224.71K, a decrease of -85.91%. That is a compound annual growth rate of -6.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 224.71K | -50.00% |
| Dec 31, 2025 | 449.42K | -75.00% |
| Dec 26, 2024 | 1.80M | -76.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abpro Holdings | 429.17K |
| Regenerative Medical Technology Group | 394.17K |
| Actavia Life Sciences | 385.91K |
| Aibotics | 377.56K |
| Altamira Therapeutics | 377.22K |
| Innovation Pharmaceuticals | 370.14K |
| Regen BioPharma | 192.38K |
| Ocean Biomedical | 185.89K |